Evidence map›Paper›PMID 19339895›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2009

Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy.

Sher L Hendrickson, Lawrence A Kingsley, Eduardo Ruiz-Pesini, Jason C Poole, Lisa P Jacobson, Frank J Palella, Jay H Bream, Douglas C Wallace, Stephen J O'Brien

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. HIV and antiretroviral therapy-related fat alterations.Nature reviews. Disease primers · 2020
    Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Sher L HendricksonLaboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702-1201. hendrickson@mail.nih.gov
Lawrence A Kingsley
Eduardo Ruiz-Pesini
Jason C Poole
Lisa P Jacobson
Frank J Palella
Jay H Bream
Douglas C Wallace
Stephen J O'Brien
Fundacion Agencia Aragonesa para la Investigacion y el Desarrollo · ESJohns Hopkins University · USInstituto de Salud Carlos III · ESNational Cancer Institute · USUniversity of California, Irvine · USUniversity of Chicago · US

Funding

NATURAL HISTORY OF AIDS IN HOMOSEXUAL MENU01AI035040 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DETELS, ROGER, MARTINEZ-MAZA, OTONIEL · 1993 to 2018
$75.2M
ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ANDERSON, GAIL V · 1985 to 2011
$74.2M
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)U01AI035041 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARTINSON, JEREMY JAMES, RINALDO, CHARLES R · 1993 to 2018
$71.4M
MULTICENTER AIDS COHORT STUDYU01AI035039 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLINSKY, STEVEN M · 1993 to 2018
$66.4M
Multicenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5M
UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
METHODOLOGICAL EXPERTISE IN INTREPRETING MACS DATAU01AI035043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBSON, LISA P · 1993 to 2011
$26.9M
MITOCHONDRIAL INBORN ERRORS OF METABOLISMR01NS021328 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI WALLACE, DOUGLAS C · 1985 to 2017
$6.5M
MULTICENTER AIDS COHORT STUDY PATHOGENESIS RESEARCH LABSU01AI037613 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JAMIESON-KARAVODIN, BETH DEIRDRE · 1995 to 2003
$3.4M
Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS CohortsZIABC010317 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI O'BRIEN, STEPHEN J · 2009 to 2011
$3.2M
MULTICENTER AIDS COHORT STUDY PATHOGENESIS RESEARCHU01AI037984 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARGOLICK, JOSEPH B. · 1995 to 2003
$3.1M
Adaptive Physiology of mtDNA Longevity MutationsR01AG024373 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI WALLACE, DOUGLAS C · 2004 to 2008
$1.9M
NCRR NIH HHS 5-M01-RR-00722NCRR NIH HHS M01 RR000425NCRR NIH HHS M01 RR000722NCRR NIH HHS M01 RR00425NCRR NIH HHS S07 RR018241NIAID NIH HHS U01 AI035039NIAID NIH HHS U01 AI035040NIAID NIH HHS U01 AI035041NIAID NIH HHS U01 AI035042NIAID NIH HHS U01 AI035043NIAID NIH HHS U01 AI037613NIAID NIH HHS U01 AI037984NIAID NIH HHS U01-AI-35039NIAID NIH HHS U01-AI-35040NIAID NIH HHS U01-AI-35041NIAID NIH HHS U01-AI-35042NIAID NIH HHS U01-AI-35043NIAID NIH HHS U01-AI-37613NIAID NIH HHS U01-AI-37984NIA NIH HHS AG16573NIA NIH HHS AG24373NIA NIH HHS AG25638NIA NIH HHS F32 AG025638NIA NIH HHS P50 AG016573NIA NIH HHS R01 AG024373NIDDK NIH HHS DK73691NIDDK NIH HHS R01 DK073691NINDS NIH HHS NS21328NINDS NIH HHS R01 NS021328
6 · The paper itself

Abstract

Although highly active antiretroviral therapy (HAART) has been extremely effective in lowering AIDS incidence among patients infected with HIV, certain drugs included in HAART can cause serious mitochondrial toxicities. One of the most frequent adverse events is lipoatrophy, which is the loss of subcutaneous fat in the face, arms, buttocks, and/or legs as an adverse reaction to nucleoside reverse transcriptase inhibitors. The clinical symptoms of lipoatrophy resemble those of inherited mitochondrial diseases, which suggest that host mitochondrial genotype may play a role in susceptibility. We analyzed the association between mitochondrial haplogroup and severity of lipoatrophy in HIV-infected European American patients on HAART in the Multicenter AIDS cohort Study and found that mitochondrial haplogroup H was strongly associated with increased atrophy [arms: P = 0.007, odds ratio (OR) = 1.77, 95% confidence interval (CI) = 1.17 to 2.69; legs: P = 0.037, OR = 1.54, 95% CI = 1.03 to 2.31; and buttocks: P = 0.10, OR = 1.41 95% CI = 0.94 to 2.12]. We also saw borderline significance for haplogroup T as protective against lipoatrophy (P = 0.05, OR = 0.52, 95% CI = 0.20 to 1.00). These data suggest that mitochondrial DNA haplogroup may influence the propensity for lipoatrophy in patients receiving nucleoside reverse transcriptase inhibitors.

Indexed as

Antiretroviral Therapy, Highly ActiveHaplotypesHIV-1AdolescentAdultAgedAnti-HIV AgentsDNA, MitochondrialGenetic Predisposition to DiseaseHIV-Associated Lipodystrophy SyndromeHumansMaleMiddle AgedPhyllachoralesPolymorphism, Single NucleotideYoung AdultAnti-HIV AgentsDNA, Mitochondrial

Identifiers

PMID19339895
PMCPMC2742970
OpenAlexW2085666957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.